Tuesday, November 5, 2024
HomeTagsFasTCAR GC012F

FasTCAR GC012F

Gracell Biotechnologies Presents Updated Clinical Data for BCMA/CD19 Dual-targeting FasTCAR GC012F

Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, announced the...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics